trump rx tirzepatide Eli Lilly lowers Zepbound price and Harris campaign hits on fiscal agenda: Morning Rundown Trump announces $50/month GLP-1 weight

For those with HNF1A mutations, addition of a DPP-4 inhibitor to the sulfonylurea may help improve glycemic variability and attainment of glycemic goals (311)

168 Wagner RL, Apriletti JW, McGrath ME, West BL, Baxter JD, Fletterick RJ

Gastroprotection should be considered in these higher-risk scenarios according to NICE Clinical Knowledge Summaries guidance

A key innovation in this field is the development of designer probioticsgenetically engineered or otherwise modified commensal bacterial strains specifically tailored to withstand production stresses such as lyophilization, thermal fluctuations, and gastric acidity, or to enhance their most beneficial functions for the host (537)